News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nuheara.
RELATED STOCKHEAD STORIES
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Why Salter Brothers is eyeing ASX small cap medtechs
News
CLOSING BELL: Surely we’ve all completely lost interest in talking about interest rates by now
News
Market Highlights: Big rally in US travel stocks, Bitcoin; and 5 ASX small caps to watch on Thursday
News
LAST ORDERS: A frantic look back at the news you might have missed today
News
LAST ORDERS: A mid-week peek at the news from the ASX and elsewhere you might have missed today
News
Market Highlights: Energy and tech pace Wall St lower, and 5 ASX small caps to watch on Thursday
Health & Biotech
ASX Biotech Stocks: HitIQ nabs landmark deal with Premier League for its concussion management tech
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Biotech Stocks: Nuheara secures historic FDA clearance for its over-the-counter hearing aid
News
ASX Quarterlies: Nuheara rockets 33pc, Dicker continues to grow, while these biotechs are all cashed up
News
Top 10 at 10: It’s Monday madness for these ASX stocks
News
Rise and Shine: Everything you need know before the ASX opens
News
Closing Bell: ASX 200 creeps up and the strongest Aussie wage growth in 8 years
News
ASX Small Caps Lunch Wrap: Who’s making an unlikely political tilt today?
News
Top 10 at 10: This ‘stunning’ 63m copper-gold hit is best on field in early trade
News
